Xuejun Chen, Ph.D.

Lab Manager, Staff Scientist 

Contact: For contact information, search the NIH Enterprise Directory.


Ph.D., Rutgers University

M.S., John Hopkins University

B.S., Peking University

Languages Spoken: Mandarin


Dr. Chen’s research focuses on development of HIV vaccines targeting the vulnerable epitopes of the HIV envelope to elicit broadly neutralizing antibodies (bnAbs), especially VRC-01 class bnAbs. He tests candidate vaccine regimens in various animal models for their ability to elicit bnAbs and isolates and characterizes the elicited antibodies to guide further vaccine design. As the lab manager, he also oversees lab operations.